Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines

S. Couillard (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), G. Hynes (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), A. Hayman (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), A. Moran (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), T. Hinks (Oxford, United Kingdom)

Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Session: Phenotypes of asthma and COPD
Session type: E-poster session
Number: 1111
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Couillard (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), G. Hynes (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), A. Hayman (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), A. Moran (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), T. Hinks (Oxford, United Kingdom). Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines. 1111

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sputum IL-26 Is Overexpressed in Severe Asthma and Induces Proinflammatory Cytokine Production and Th17 Cell Generation: A Case–Control Study of Women
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


1-?-alkyl-glycerols Reduce Level of Inflammatory Cytokines In Obese Asthma
Source: Virtual Congress 2021 – Pharmacology of airway diseases: clinical and laboratory studies
Year: 2021


Aerobic Exercise Improves Asthma Phenotype in a Model of Severe Asthma: Involvement of Kinins
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019


Inflammatory Pathways and Mediators in the Pathogenesis of Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007


Blood Eosinophils Correlate With Severe Exacerbations in Frequent Exacerbator Phenotype of COPD
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Distinct Tryptase and CPA3-positive Basophil Phenotypes in Healthy Individuals, Asthma, and COPD
Source: International Congress 2017 – New immune markers for asthma and COPD
Year: 2017



Biology and Role of Type 2 Airway Inflammation
Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics
Year: 2017

Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019


Late Breaking Abstract -  Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017



Peripheral Blood Eosinophils as Marker of Sputum Eosinophilia and Outocome of COPD Exacerbation
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Allergy Testing in Asthmatics and Severe Asthmatics in Belgium : Role of Comorbidities
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020


Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
Source: International Congress 2014 – Airway biomarkers
Year: 2014


LATE-BREAKING ABSTRACT: Blood Eosinophil Count as a Biomarker of ICS Effectiveness in Reducing Exacerbation Rates in COPD
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014


Clinical Evidence for Targeted Strategies in Asthma with Type 2 Inflammation: Single and Dual Inhibition
Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics
Year: 2017

The 6 Gene Signature in Whole Sampled Sputum provides Clinically Feasible Inflammatory Phenotyping of Asthma
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019


Co-Morbidities Are Serious Confounders of Asthma in Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007


The Effect of Bronchial Thermoplasty on Lung Function in Severe Asthma Patients
Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction
Year: 2018



Microbiome Characteristics of Induced Sputum compared to Bronchial Fluid and Upper Airway Samples
Source: International Congress 2018 – Paediatric respiratory infections: translational and clinical perspectives
Year: 2018



Creatine Supplementation Augments Chronic Allergic Airway Inflammation and Remodelling: from Mice to Human Evidence
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018